Vaccine News and Research

Latest Vaccine News and Research

Viewpoints: Blocking, replacing health law; a doc's HPV advice; County wellness plan working

Too often, the Republican Party health-care agenda seems to consist of incanting "repeal and replace" and then to stop thinking - if the thinking ever begins at all. Certainly the current Presidential field is saying little beyond promising to repeal ObamaCare, but in the nick of time Paul Ryan has provided some intellectual guidance in an important speech yesterday at Stanford's Hoover Institution. he said "we cannot simply revert to the status quo."

29 Sep 2011

Phase I clinical trials reveal MVA-B preventive vaccine's immune efficiency against HIV

Phase I clinical trials developed by Spanish Superior Scientific Research Council (CSIC) together with Gregorio Mara--n Hospital in Madrid and Cl-nic Hospital in Barcelona, reveals MVA-B preventive vaccine's immune efficiency against Human's immunodeficiency virus (HIV).

28 Sep 2011

Anthrax defenses need to be strengthened: Experts

It has been a decade since the anthrax attacks brought home the reality of bioterrorism and the nation now has a stockpile of some basic tools to fight back against a few of the threats that worry defense experts the most.

28 Sep 2011

GAVI to purchase $1 billion in childhood vaccines for distribution in 37 of the poorest nations

The Geneva-based GAVI Alliance, a fund backed by governments, the World Bank, the WHO and the Bill & Melinda Gates Foundation, said in an e-mailed statement on Tuesday that it will purchase more than $1 billion in vaccines against rotavirus, pneumococcal and other diseases through deals made with GlaxoSmithKline, Pfizer Inc. and Merck & Co. to immunize children in 37 of the poorest nations, Bloomberg reports.

28 Sep 2011

High prevalence of NTDs in Central Asia after 1991 collapse of the Soviet Union

The open-access journal PLoS Neglected Tropical Diseases will publish an article emphasizing the rising burden of Neglected Tropical Diseases (NTDs) in Central Asia on Tuesday, Sept. 27th.

28 Sep 2011

More predictability in the chaos of infectious Chagas disease transmission

Despite what Hollywood would have you believe, not all epidemics involve people suffering from zombie-like symptoms--some can only be uncovered through door-to-door epidemiology and advanced mathematics.

28 Sep 2011

Microbiologist offers advice to guard against coming down with the flu

October marks the beginning of flu season, and once again, health care professionals are exhorting people to get a flu shot. Microbiologist John Tudor, Ph.D., professor of biology at Saint Joseph's University in Philadelphia, agrees that it's time to roll up our sleeves and offer up our arms for the vaccination.

28 Sep 2011

Lead compound activates infection-fighting REDD1 protein and kills flu strain

A compound tested by UT Southwestern Medical Center investigators destroys several viruses, including the deadly Spanish flu that killed an estimated 30 million people in the worldwide pandemic of 1918.

27 Sep 2011

Immediate action needed to curb spread of TB, especially among children

In this post in the Huffington Posts "Impact" blog, Kolleen Bouchane, director of ACTION, an international partnership of advocates working to mobilize resources to treat and prevent the spread of tuberculosis (TB), examines the need for improved TB vaccines and diagnostics in order to curb the spread of multidrug-resistant TB, especially among children, and highlights ACTION's new report.

27 Sep 2011

HIV vaccine research showing promise

Recent findings on HIV vaccine research, some presented recently at the AIDS Vaccine 2011 conference in Bangkok, "show that the science of an AIDS vaccine is vibrant and vital," Mitchell Warren, executive director of AVAC-Global Advocacy for HIV Prevention, writes in a "Science Speaks" guest blog post.

27 Sep 2011

Rush Foundation, Copenhagen Consensus Center examine how to spend hypothetical AIDS funding

In this post in the Center for Global Developments "Global Health Policy" blog, Mead Over, a senior fellow at the center, writes that the Rush Foundation has asked the Copenhagen Consensus Centre to address the question of how to spend an additional, but hypothetical, $10 billion on HIV/AIDS programs in Africa over the next five years.

27 Sep 2011

Researchers modify HIV in a way that makes it no longer able to suppress immune system

Researchers at Johns Hopkins have modified HIV in a way that makes it no longer able to suppress the immune system. Their work, they say in a report published online September 19 in the journal Blood, could remove a major hurdle in HIV vaccine development and lead to new treatments.

27 Sep 2011

University of Zurich receives AICR grant to improve vaccines against Burkitt's lymphoma

Research in Switzerland could help reduce the time taken to develop vaccines against cancer tumours.

27 Sep 2011

MSU creates new malaria vaccine with immune-stimulating gene

Continuing a global effort to prevent malaria infections, Michigan State University researchers have created a new malaria vaccine - one that combines the use of a disabled cold virus with an immune system-stimulating gene - that appears to increase the immune response against the parasite that causes the deadly disease.

27 Sep 2011

Roundup: Patient dies after medical error during Calif. nurses strike; grocery workers ratify contract that had partially hinged on health care

Veteran nurses locked out of Alta Bates Summit Medical Center in Oakland said Sunday that the death of a patient due to a medical error by a replacement worker wouldn't have happened if they had been allowed to do their jobs. The hospital's management countered that it was a freak accident that could have happened at any time -- with or without the replacement nurses. At the center of the dispute is a cancer patient, a woman who has not been identified but whose tragic death on Saturday has inflamed an already tense labor dispute.

27 Sep 2011

Vaxent, PREVENT sign license agreement to develop and commercialize Strep-A vaccine

An international collaboration between Vaxent, a Memphis-based early stage vaccine development company in the Memphis Bioworks Foundation Incubator, and The Pan-Provincial Vaccine Enterprise Inc. (PREVENT), a Centre of Excellence for Commercialization and Research (CECR) in Saskatchewan, has put a vaccine for group A streptococcus (Strep-A) back on the path for potential commercialization.

26 Sep 2011

Afinitor Phase III study on angiomyolipomas associated with TSC meets primary endpoint

A Phase III study of Afinitor (everolimus) tablets in patients with non-cancerous kidney tumors, or angiomyolipomas, associated with tuberous sclerosis complex (TSC) met its primary endpoint of best overall angiomyolipoma response rate, which includes reduction in kidney tumor size and absence of new tumors.

26 Sep 2011

Combination of Afinitor, exemestane reduces risk of breast cancer progression in women

A pivotal Phase III study shows Afinitor (everolimus) tablets plus exemestane, a hormonal therapy, more than doubled the time women lived without tumor growth (progression-free survival; PFS) and significantly reduced the risk of cancer progression by 57% versus exemestane alone in patients with advanced breast cancer.

26 Sep 2011

Fact check: Health care claims in Republican debate

News organizations have been looking into candidates' statements from Thursday night's debate, including one by Gov. Rick Perry about Mitt Romney's book, Rep. Michele Bachmann and Perry on the HPV vaccine and Herman Cain on his cancer and the health law.

26 Sep 2011

Britain’s health workers urged to get flu shots to protect patients

Britain’s National Health Service (NHS) is urging its staff to take their flu shots amid fresh warnings that low vaccination rates among health professionals could lead to vulnerable patients getting infected and dying. The NHS's employers, health trade unions and the Department of Health have launched a campaign to tackle low immunization rates among frontline staff such as doctors and nurses.

26 Sep 2011

Vaccine News and Research

Latest Vaccine News and Research

Viewpoints: Blocking, replacing health law; a doc's HPV advice; County wellness plan working

Phase I clinical trials reveal MVA-B preventive vaccine's immune efficiency against HIV

Anthrax defenses need to be strengthened: Experts

GAVI to purchase $1 billion in childhood vaccines for distribution in 37 of the poorest nations

High prevalence of NTDs in Central Asia after 1991 collapse of the Soviet Union

More predictability in the chaos of infectious Chagas disease transmission

Microbiologist offers advice to guard against coming down with the flu

Lead compound activates infection-fighting REDD1 protein and kills flu strain

Immediate action needed to curb spread of TB, especially among children

HIV vaccine research showing promise

Rush Foundation, Copenhagen Consensus Center examine how to spend hypothetical AIDS funding

Researchers modify HIV in a way that makes it no longer able to suppress immune system

University of Zurich receives AICR grant to improve vaccines against Burkitt's lymphoma

MSU creates new malaria vaccine with immune-stimulating gene

Roundup: Patient dies after medical error during Calif. nurses strike; grocery workers ratify contract that had partially hinged on health care

Vaxent, PREVENT sign license agreement to develop and commercialize Strep-A vaccine

Afinitor Phase III study on angiomyolipomas associated with TSC meets primary endpoint

Combination of Afinitor, exemestane reduces risk of breast cancer progression in women

Fact check: Health care claims in Republican debate

Britain’s health workers urged to get flu shots to protect patients

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Evolving spectrophotometry for modern biopharma workflows

Vaccine News and Research

Latest Vaccine News and Research

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Evolving spectrophotometry for modern biopharma workflows

Newsletters you may be interested in